您的位置: 首页 > 2017年3月 第48卷 第2期 > 文字全文
2023年7月 第38卷 第7期11
目录

高血压合并代谢综合征患者血清瘦素与靶器官损伤的研究进展

Research progress of serum leptin level and target organ damage in patients with hypertension complicated with metabolic syndrome

来源期刊: 广州医药 | 105-108 发布时间:2021-12-01 收稿时间:2025/11/13 17:14:33 阅读量:147
作者:
关键词:
瘦素瘦素抵抗高血压代谢综合征靶器官损伤
LeptinLeptin resistanceHypertensionMetabolic syndromeTarget organ damage
DOI:
10.3969/j.issn.1000-8535.2017.02.030
收稿时间:
2016-11-11 
修订日期:
 
接收日期:
 
引用总数:
0  
瘦素是维持人体能量代谢平衡的蛋白质,在人体中主要由白色脂肪组织分泌,通过与瘦素受体结合发挥作用。近年来有许多与瘦素相关的研究证明高血压患者及代谢综合征患者的血清瘦素水平较健康人群明显升高。两种疾病均可出现心室肥厚,蛋白尿,动脉粥样硬化等表现,说明二者存在共同的靶器官。瘦素代谢异常可出现瘦素抵抗并通过影响肾素-血管紧张素-醛固酮系统(renin angiotensin aldosterone system, RAAS)及炎症细胞因子来损伤靶器官。本文旨在总结瘦素在高血压及代谢综合征中的作用机制,并探讨瘦素对高血压合并代谢综合征靶器官损伤作用的研究进展。
Leptin is a protein that maintains the balance of energy metabolism in human body. It is mainly secreted by white adipose tissue in human body. In recent years, many studies have shown that the serum leptin level in patients with hypertension complicated with metabolic syndrome is significantly higher than that of healthy people. Both of the diseases can lead to left ventricular hypertrophy, proteinuria, atherosclerosis and other manifestations. The abnormal metabolism of leptin may contribute to leptin resistance which damages target organs by affecting the angiotensin aldosterone system and inflammatory cytokines. The aim of this article is to summarize the mechanism of leptin in hypertension and metabolic syndrome, and to explore its effect on the target organ damage in patients with hypertension complicated with metabolic syndrome.
1、 KAMIDE K. Role of renin-Angiotensin-Aldosterone system in metabolic syndrome and obesity-related hypertension[J]. Curr Hypertens Rev, 2014,9(4):238-245. KAMIDE K. Role of renin-Angiotensin-Aldosterone system in metabolic syndrome and obesity-related hypertension[J]. Curr Hypertens Rev, 2014,9(4):238-245.
2、 LI H, LI M, LIU P, et al. Telmisartan ameliorates nephropathy in metabolic syndrome by reducing leptin release from perirenal adipose tissue[J]. Hypertension, 2016, 68(2):478-490. LI H, LI M, LIU P, et al. Telmisartan ameliorates nephropathy in metabolic syndrome by reducing leptin release from perirenal adipose tissue[J]. Hypertension, 2016, 68(2):478-490.
3、 MALEKI A, MONTAZERI M, RASHIDI N, et al. Metabolic syndrome and its components associated with chronic kidney disease[J]. J Res Med Sci, 2015, 20(5):465-469. MALEKI A, MONTAZERI M, RASHIDI N, et al. Metabolic syndrome and its components associated with chronic kidney disease[J]. J Res Med Sci, 2015, 20(5):465-469.
4、 CAPOULADE R, CLAVEL M A, DUMESNIL J G, et al. Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial[J]. JACC Cardiovasc Imaging, 2013, 6(2):165-174. CAPOULADE R, CLAVEL M A, DUMESNIL J G, et al. Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial[J]. JACC Cardiovasc Imaging, 2013, 6(2):165-174.
5、 AL-DAYDAMONY M M, EL-TAHLAWI M. What is the effect of metabolic syndrome without hypertension on left ventricular hypertrophy? [J]. Echocardiography, 2016, 33(9):1284-1289. AL-DAYDAMONY M M, EL-TAHLAWI M. What is the effect of metabolic syndrome without hypertension on left ventricular hypertrophy? [J]. Echocardiography, 2016, 33(9):1284-1289.
6、 OSEGBE I, OKPARA H, AZINGE E. Relationship between serum leptin and insulin resistance among obese Nigerian women[J]. Ann Afr Med, 2016, 15(1):14-19. OSEGBE I, OKPARA H, AZINGE E. Relationship between serum leptin and insulin resistance among obese Nigerian women[J]. Ann Afr Med, 2016, 15(1):14-19.
7、 FATIMA S S, ALAM F, CHAUDHRY B,et al.Elevated levels of chemerin, leptin, and interleukin-18 in gestational diabetes mellitus[J]. J Matern Fetal Neonatal Med, 2016(29):1-6. FATIMA S S, ALAM F, CHAUDHRY B,et al.Elevated levels of chemerin, leptin, and interleukin-18 in gestational diabetes mellitus[J]. J Matern Fetal Neonatal Med, 2016(29):1-6.
8、 LI W, HSIAO K, CHEN I, et al. Serum leptin is associated with cardiometabolic risk and predicts metabolic syndrome in Taiwanese adults[J]. Cardiovasc Diabetol, 2011(10): 36. LI W, HSIAO K, CHEN I, et al. Serum leptin is associated with cardiometabolic risk and predicts metabolic syndrome in Taiwanese adults[J]. Cardiovasc Diabetol, 2011(10): 36.
9、 SHANKAR A, SYAMALA S, XIAO J, et al. Relationship between plasma leptin level and chronic kidney disease [J]. Int J Nephrol, 2012(2012):269532. SHANKAR A, SYAMALA S, XIAO J, et al. Relationship between plasma leptin level and chronic kidney disease [J]. Int J Nephrol, 2012(2012):269532.
10、 ALIX P M, GUEBRE-EGZIABHER F, SOULAGE C O. Leptin as an uremic toxin: Deleterious role of leptin in chronic kidney disease [J]. Biochimie, 2014, 105(10):12-21. ALIX P M, GUEBRE-EGZIABHER F, SOULAGE C O. Leptin as an uremic toxin: Deleterious role of leptin in chronic kidney disease [J]. Biochimie, 2014, 105(10):12-21.
11、 FRISK M L. Inflammation resolution: a solution for advanced atherosclerosis [J]. Sci Signal, 2015, 8(365):43. FRISK M L. Inflammation resolution: a solution for advanced atherosclerosis [J]. Sci Signal, 2015, 8(365):43.
12、 ZEIDAN A, HUNTER J C, JAVADOV S, et al. mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy[J]. Mol Cell Biochem, 2011, 352(1/2): 99-108. ZEIDAN A, HUNTER J C, JAVADOV S, et al. mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy[J]. Mol Cell Biochem, 2011, 352(1/2): 99-108.
13、 XUE B, YU Y, ZHANG Z, et al. Leptin mediates high-fat diet sensitization of angiotensin II-Elicited hypertension by upregulating the brain renin-angiotensin system and inflammation[J]. Hypertension, 2016, 67(5):970-976. XUE B, YU Y, ZHANG Z, et al. Leptin mediates high-fat diet sensitization of angiotensin II-Elicited hypertension by upregulating the brain renin-angiotensin system and inflammation[J]. Hypertension, 2016, 67(5):970-976.
14、 RAMíREZ S, CLARET M. Hypothalamic ER stress: A bridge between leptin resistance and obesity[J]. FEBS Lett, 2015, 589(14):1678-1687. RAMíREZ S, CLARET M. Hypothalamic ER stress: A bridge between leptin resistance and obesity[J]. FEBS Lett, 2015, 589(14):1678-1687.
15、 S NDA LIMA, E de OLIVEIRA, AP da SILVA, et al. Effects of Ilex paraguariensis (yerba mate) treatment on leptin resistance and inflammatory parameters in obese rats primed by early weaning[J]. Life Sci, 2014, 115(1-2):29-35. S NDA LIMA, E de OLIVEIRA, AP da SILVA, et al. Effects of Ilex paraguariensis (yerba mate) treatment on leptin resistance and inflammatory parameters in obese rats primed by early weaning[J]. Life Sci, 2014, 115(1-2):29-35.
16、 KOHARA K, OCHI M, OKADA Y, et al. Clinical characteristics of high plasma adiponectin and high plasma leptin as risk factors for arterial stiffness and related end-organ damage[J]. Atherosclerosis, 2014, 235(2):424-429. KOHARA K, OCHI M, OKADA Y, et al. Clinical characteristics of high plasma adiponectin and high plasma leptin as risk factors for arterial stiffness and related end-organ damage[J]. Atherosclerosis, 2014, 235(2):424-429.
17、 CRUJEIRAS A B, CARREIRA M C, CABIA B, et al. Leptin resistance in obesity: An epigenetic landscape[J]. Life Sci, 2015(140):57-63. CRUJEIRAS A B, CARREIRA M C, CABIA B, et al. Leptin resistance in obesity: An epigenetic landscape[J]. Life Sci, 2015(140):57-63.
18、 CARMICHAEL C Y, WAINFORD R D. Hypothalamic signaling mechanisms in hypertension[J]. Curr Hypertens Rep, 2015, 17(5):39. CARMICHAEL C Y, WAINFORD R D. Hypothalamic signaling mechanisms in hypertension[J]. Curr Hypertens Rep, 2015, 17(5):39.
19、 BASSI M, FURUYA W I, ZOCCAL D B, et al. Facilitation of breathing by leptin effects in the central nervous system[J]. J Physiol, 2016, 594(6):1617-1625. BASSI M, FURUYA W I, ZOCCAL D B, et al. Facilitation of breathing by leptin effects in the central nervous system[J]. J Physiol, 2016, 594(6):1617-1625.
20、 BARNES M J, MCDOUGAL D H. Leptin into the rostral ventral lateral medulla (RVLM) augments renal sympathetic nerve activity and blood pressure[J]. Front Neurosci, 2014, 8:232. BARNES M J, MCDOUGAL D H. Leptin into the rostral ventral lateral medulla (RVLM) augments renal sympathetic nerve activity and blood pressure[J]. Front Neurosci, 2014, 8:232.
21、 ALTIRRIBA J, POHER A L, ROHNER-JEANRENAUD F. Chronic Oxytocin administration as a treatment against impaired leptin signaling or leptin resistance in obesity[J]. Front Endocrinol (Lausanne), 2015(6):119. ALTIRRIBA J, POHER A L, ROHNER-JEANRENAUD F. Chronic Oxytocin administration as a treatment against impaired leptin signaling or leptin resistance in obesity[J]. Front Endocrinol (Lausanne), 2015(6):119.
22、 MELE P, ZAMMARETTI F, LONGO A, et al. Sex-dependent regulation of hypothalamic neuropeptide Y-Y1 receptor gene expression in leptin treated obese (ob/ob) or lean mice[J]. Brain Res, 2016, 1649(Pt A):102-109. MELE P, ZAMMARETTI F, LONGO A, et al. Sex-dependent regulation of hypothalamic neuropeptide Y-Y1 receptor gene expression in leptin treated obese (ob/ob) or lean mice[J]. Brain Res, 2016, 1649(Pt A):102-109.
23、 ZHOU Y, RUI L. Leptin signaling and leptin resistance [J]. Front Med, 2013, 7(2):207-222. ZHOU Y, RUI L. Leptin signaling and leptin resistance [J]. Front Med, 2013, 7(2):207-222.
24、 I ROSTáS, TENK J, MIKó A,et al. Age-related changes in acute central leptin effects on energy balance are promoted by obesity[J]. Exp Gerontol, 2016, 85:118-127. I ROSTáS, TENK J, MIKó A,et al. Age-related changes in acute central leptin effects on energy balance are promoted by obesity[J]. Exp Gerontol, 2016, 85:118-127.
25、 ALKHOLY U M, AHMED I A, KARAM N A, et al. Assessment of left ventricular mass index could predict metabolic syndrome in obese children[J]. J Saudi Heart Assoc, 2016, 28(3):159-166. ALKHOLY U M, AHMED I A, KARAM N A, et al. Assessment of left ventricular mass index could predict metabolic syndrome in obese children[J]. J Saudi Heart Assoc, 2016, 28(3):159-166.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录